Growth Metrics

Biogen (BIIB) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $20.6 billion.

  • Biogen's Retained Earnings rose 671.29% to $20.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.6 billion, marking a year-over-year increase of 671.29%. This contributed to the annual value of $20.6 billion for FY2025, which is 671.29% up from last year.
  • Latest data reveals that Biogen reported Retained Earnings of $20.6 billion as of Q4 2025, which was up 671.29% from $20.6 billion recorded in Q3 2025.
  • In the past 5 years, Biogen's Retained Earnings ranged from a high of $20.6 billion in Q3 2025 and a low of -$174.3 million during Q1 2021
  • For the 5-year period, Biogen's Retained Earnings averaged around $8.6 billion, with its median value being -$108.6 million (2021).
  • Its Retained Earnings has fluctuated over the past 5 years, first crashed by 5652.17% in 2023, then skyrocketed by 1202285.0% in 2024.
  • Biogen's Retained Earnings (Quarter) stood at -$106.7 million in 2021, then crashed by 54.55% to -$164.9 million in 2022, then soared by 10789.87% to $17.6 billion in 2023, then increased by 9.26% to $19.3 billion in 2024, then increased by 6.71% to $20.6 billion in 2025.
  • Its Retained Earnings was $20.6 billion in Q4 2025, compared to $20.6 billion in Q3 2025 and $20.1 billion in Q2 2025.